Keyphrases
Acute Lymphoblastic Leukemia
49%
Acute Myeloid Leukemia
20%
Allogeneic Bone Marrow Transplantation
23%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
43%
Anemia Type
20%
Apoptosis
33%
Bone Marrow
48%
Bone Marrow Cells
19%
Bone Marrow Transplantation
40%
Chemotherapy
40%
Childhood Acute Lymphoblastic Leukemia
39%
Congenital Dyserythropoietic Anemia
20%
Engraftment
27%
European Society
23%
Event-free Survival
39%
Ewing Sarcoma
46%
Ewing Sarcoma Family of Tumors
16%
Fanconi Anemia
15%
Fas Ligand
36%
Fertility Preservation
15%
Graft-versus-host Disease (GvHD)
33%
Hematopoietic Cells
20%
Hematopoietic Stem Cell Transplantation
44%
Hematopoietic Stem Cells
30%
High Dose
15%
High-risk Neuroblastoma
18%
Israel
40%
Israeli
36%
Leukemia
17%
Marrow Transplantation
37%
Neuroblastoma
59%
NOD Mice
15%
Overall Survival
31%
Pediatric
35%
Pediatric Diseases
22%
Pediatric Hematology
24%
Pediatric Hematopoietic Stem Cell Transplantation
18%
Pediatric Oncology
15%
Pediatric Patients
37%
Peripheral Blood Stem Cell Collection
15%
Quantitative PCR
18%
Risk Factors
19%
Stem Cell Transplantation
22%
Survivors
19%
T Cells
20%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
16%
Transplantation
36%
Tumor
30%
Working Diagnosis
22%
Working Party
19%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
64%
Acute Myeloid Leukemia
24%
Allogeneic Hematopoietic Stem Cell Transplantation
20%
B Cell
12%
Bloodstream Infection
15%
Bone Marrow Transplantation
34%
Cancer
13%
Central Venous Catheter
19%
Childhood Cancer
33%
Conditioning
23%
Cord Blood
15%
Cord Blood Stem Cell Transplantation
14%
Diseases
100%
Drug Megadose
20%
Endocrine Disease
13%
Engraftment
29%
Event Free Survival
31%
Ewing Sarcoma
33%
Fas Ligand
16%
Fertility Preservation
15%
Ganglioneuroblastoma
43%
Graft Versus Host Reaction
24%
Hematopoietic Cell
29%
Hematopoietic Stem Cell Transplantation
56%
High Dose Chemotherapy
11%
Idiopathic Thrombocytopenic Purpura
11%
In Vitro
13%
Infection
17%
Intracranial Tumor
11%
Leukemia
28%
Malignant Neoplasm
37%
Matched Donor
12%
Methotrexate
13%
Minimal Residual Disease
13%
Neoplasm
57%
Oncology
28%
Overall Survival
34%
Pediatric Disease
18%
Pediatric Hematology
22%
Pediatrics
81%
Pediatrics Patient
36%
Peripheral Blood Stem Cell
16%
Programmed Cell Death
18%
Recurrent Disease
12%
Sickle-Cell Disease
13%
Stem Cell
28%
Stem Cell Therapy
17%
Supportive Care
15%
T Cell
24%
Tumor Cell
11%